Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
- Conditions
- SchizophreniaPsychoses
- Interventions
- Registration Number
- NCT00159133
- Lead Sponsor
- Heinrich-Heine University, Duesseldorf
- Brief Summary
Prodrome based early intervention with an antipsychotic drug vs. benzodiazepine was applied in patients with first episode schizophrenia after one year neuroleptic maintenance treatment. Two groups of patients were followed over a period of 1 year: one further on under maintenance neuroleptic treatment, the other one after stepwise drug discontinuation.
- Detailed Description
In case of early signs of a relapse prodrome based early intervention with an antipsychotic drug (Haloperidol, Risperidone and other) vs. benzodiazepine (Lorazepam) was applied in patients with first episode schizophrenia after one year neuroleptic maintenance treatment. Two groups of patients were followed over a period of 1 year: one further on under maintenance neuroleptic treatment (Haloperidol, Risperidone and other) , the other one after stepwise drug discontinuation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 71
- First-episode in schizophrenia (according ICD-10 F20)
- Age between 18 and 55
- Informed consent
- One year neuroleptic maintenance treatment
- Residence outside of the catchment area
- Legal reasons
- Insufficient knowledge of the german language
- Substance abuse or addiction
- Pregnancy
- Serious physical illness
- Organic brain disease
- Contraindication to neuroleptic treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 antipsychotics vs. Lorazepam (Drugs) Early intervention with benzodiazepines in case of prodromal symptoms of an impending relapse 2 antipsychotics vs. Lorazepam (Drugs) Early intervention with antipsychotics in case of prodromal symptoms of an impending relapse
- Primary Outcome Measures
Name Time Method relapse rate 1 year
- Secondary Outcome Measures
Name Time Method quality of life 1 year social and cognitive functioning 1 year psychopathology 1 year side-effects 1 year drop-out 1 year
Trial Locations
- Locations (1)
German Research Network on Schizophrenia, Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University Düsseldorf
🇩🇪Düsseldorf, North Rhine-Westphalia, Germany